Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring CD64 on Neutrophils Regarding Effects of Antibiotics in Patients With SIRS Developing Sepsis

NCT02922998 is registered in ClinicalTrials.gov with University of Ulm as lead sponsor.

NCT NCT02922998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02922998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring CD64 on Neutrophils Regarding Effects of Antibiotics in Patients With SIRS Developing Sepsis
Lead sponsor
University of Ulm
Phase
Observational
Overall status
Completed
Start date
September 30, 2016
Completion date
June 30, 2021
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic resistant infection, critical illness, sepsis, sirs